PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
UNG vs. XBI
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


UNGXBI
YTD Return-38.21%16.84%
1Y Return-50.59%56.69%
3Y Return (Ann)-42.68%-6.75%
5Y Return (Ann)-32.36%4.50%
10Y Return (Ann)-28.44%6.36%
Sharpe Ratio-0.921.89
Sortino Ratio-1.392.60
Omega Ratio0.851.31
Calmar Ratio-0.520.81
Martin Ratio-1.326.53
Ulcer Index39.47%7.70%
Daily Std Dev56.39%26.60%
Max Drawdown-99.85%-63.89%
Current Drawdown-99.85%-40.01%

Correlation

-0.50.00.51.00.0

The correlation between UNG and XBI is 0.03, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Performance

UNG vs. XBI - Performance Comparison

In the year-to-date period, UNG achieves a -38.21% return, which is significantly lower than XBI's 16.84% return. Over the past 10 years, UNG has underperformed XBI with an annualized return of -28.44%, while XBI has yielded a comparatively higher 6.36% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


-100.00%0.00%100.00%200.00%300.00%400.00%500.00%JuneJulyAugustSeptemberOctoberNovember
-99.81%
539.37%
UNG
XBI

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


UNG vs. XBI - Expense Ratio Comparison

UNG has a 1.28% expense ratio, which is higher than XBI's 0.35% expense ratio.


UNG
United States Natural Gas Fund LP
Expense ratio chart for UNG: current value at 1.28% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%1.28%
Expense ratio chart for XBI: current value at 0.35% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.35%

Risk-Adjusted Performance

UNG vs. XBI - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for United States Natural Gas Fund LP (UNG) and SPDR S&P Biotech ETF (XBI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


UNG
Sharpe ratio
The chart of Sharpe ratio for UNG, currently valued at -0.92, compared to the broader market-2.000.002.004.006.00-0.92
Sortino ratio
The chart of Sortino ratio for UNG, currently valued at -1.39, compared to the broader market-2.000.002.004.006.008.0010.0012.00-1.39
Omega ratio
The chart of Omega ratio for UNG, currently valued at 0.85, compared to the broader market1.001.502.002.503.000.85
Calmar ratio
The chart of Calmar ratio for UNG, currently valued at -0.52, compared to the broader market0.005.0010.0015.00-0.52
Martin ratio
The chart of Martin ratio for UNG, currently valued at -1.32, compared to the broader market0.0020.0040.0060.0080.00100.00-1.32
XBI
Sharpe ratio
The chart of Sharpe ratio for XBI, currently valued at 1.89, compared to the broader market-2.000.002.004.006.001.89
Sortino ratio
The chart of Sortino ratio for XBI, currently valued at 2.60, compared to the broader market-2.000.002.004.006.008.0010.0012.002.60
Omega ratio
The chart of Omega ratio for XBI, currently valued at 1.31, compared to the broader market1.001.502.002.503.001.31
Calmar ratio
The chart of Calmar ratio for XBI, currently valued at 0.81, compared to the broader market0.005.0010.0015.000.81
Martin ratio
The chart of Martin ratio for XBI, currently valued at 6.53, compared to the broader market0.0020.0040.0060.0080.00100.006.53

UNG vs. XBI - Sharpe Ratio Comparison

The current UNG Sharpe Ratio is -0.92, which is lower than the XBI Sharpe Ratio of 1.89. The chart below compares the historical Sharpe Ratios of UNG and XBI, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.50-1.00-0.500.000.501.001.502.00JuneJulyAugustSeptemberOctoberNovember
-0.92
1.89
UNG
XBI

Dividends

UNG vs. XBI - Dividend Comparison

UNG has not paid dividends to shareholders, while XBI's dividend yield for the trailing twelve months is around 0.14%.


TTM20232022202120202019201820172016201520142013
UNG
United States Natural Gas Fund LP
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
XBI
SPDR S&P Biotech ETF
0.14%0.02%0.00%0.04%0.20%0.00%0.28%0.24%0.26%0.61%1.07%0.17%

Drawdowns

UNG vs. XBI - Drawdown Comparison

The maximum UNG drawdown since its inception was -99.85%, which is greater than XBI's maximum drawdown of -63.89%. Use the drawdown chart below to compare losses from any high point for UNG and XBI. For additional features, visit the drawdowns tool.


-100.00%-90.00%-80.00%-70.00%-60.00%-50.00%-40.00%JuneJulyAugustSeptemberOctoberNovember
-99.85%
-40.01%
UNG
XBI

Volatility

UNG vs. XBI - Volatility Comparison

United States Natural Gas Fund LP (UNG) has a higher volatility of 14.55% compared to SPDR S&P Biotech ETF (XBI) at 5.37%. This indicates that UNG's price experiences larger fluctuations and is considered to be riskier than XBI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%JuneJulyAugustSeptemberOctoberNovember
14.55%
5.37%
UNG
XBI